Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated to version v2.13.2, with the status changed to 'Completed', while the previous status of 'Active, not recruiting' has been removed.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has removed the detailed options for downloading data in various formats and the selection of specific data fields related to clinical studies.SummaryDifference13%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.SummaryDifference16%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.6%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.